Japan Scientists Identify iPS Cells That Lack Differentiation Ability
This article was originally published in PharmAsia News
Japan researchers report discovery of human genes that tell them which induced pluripotent stem cells lack the ability to differentiate, making it easier to remove them before using them in regenerative medicine.
You may also be interested in...
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.
A PwC analysis finds biopharma aggregate deal value declined 87% during the first half compared to the second half of 2018; deal volume dropped 17%. The pandemic was a cause, but not the only factor.
Also, Osmotica licenses rights to ophthalmic drug in Japan, China and the EMEA nations to Santen; Lilly and Chi-Med revise their partnership around colorectal cancer drug Elunate.